NCT04250545 2026-05-26Testing of the Anti Cancer Drugs CB-839 HCl (Telaglenastat) and MLN0128 (Sapanisertib) in Advanced Stage Non-small Cell Lung CancerNational Cancer Institute (NCI)Phase 1 Active not recruiting22 enrolled 14 charts